Cerebras Systems Inc.
CBRS
Sync financial data to generate a health grade for this company.
Analytical Summary
Review the statement evidence below to form a view on CBRS.
4-Year Financial Trajectory
QuarterlyStatement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|
| Revenue Growth YoY (%) |
94.4%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+686%)
|
— | — | — |
| EPS Growth YoY (%) |
52.2%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — | — |
| Net Income Growth YoY (%) |
41.3%
Excellent
Excellent
Year-over-year change in net income |
— | — | — |
| FCF Growth YoY (%) |
35.3%
Excellent
Excellent
Year-over-year change in free cash flow |
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|
| Operating Margin (%) (%) |
-7.8%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-139%)
|
— |
-28.6%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-243%)
|
— |
| Effective Tax Rate (%) (%) |
-12.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
-7.6%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
| Profit Margin (%) (%) |
-7.2%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-148%)
|
— |
-24.0%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-260%)
|
— |
| FCF Margin (%) (%) |
-61.9%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
-153.9%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
| FCF / Net Income (x) |
8.54x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
6.42x
Excellent
Excellent
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
-10.1%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
3.1%
Weak
Weak
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
| Return on Capital (%) (%) |
-0.3%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — | — |
| Return on Common Equity (%) (%) |
7.2%
Caution
Caution
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-61%)
|
— |
2.4%
Weak
Weak
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-87%)
|
— |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
-1.86x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-513%)
|
0.00x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-100%)
|
— | — |
| Net Debt (USD) | $-1.35B | $-701.71M | — | — |
| Debt / EBITDA (x) |
115.24x
Weak
Weak
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — | — |
| Metric | Q1 FY2026 Mar 31, 2026 10-Q ↗ | Q4 FY2025 Dec 31, 2025 10-Q ↗ | Q1 FY2025 Mar 31, 2025 10-Q ↗ | Q4 FY2024 Dec 31, 2024 10-Q ↗ |
|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $193.41M | — | $99.51M | — |
| Depreciation Expense (USD) | $18.18M | — | $3.91M | — |
| Net Income, GAAP (USD) | $-14.01M | — | $-23.87M | — |
| Operating Cash Flow (USD) | $12.34M | — | $-54.94M | — |
Secondary lens
Benchmark Lens
Compare CBRS against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CBRS against peers after checking the statement evidence.
Compare CBRS with peers
Stack CBRS against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago